AllCells LLC Announces Facilities Expansion

EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells LLC (the “Company”), a leading supplier of primary cell types, today announced it has completed its expansion into 10,000 additional square feet of office and laboratory production space located in Emeryville, California.

“We have experienced dramatic growth over the past few years; in a recent market survey, >90% of AllCells’ customers reported being very satisfied with our products & service, with more than one third expecting to increase their business.”

The newly leased space, adjacent to AllCells’ headquarters, will be used to meet the rapidly growing demand for the Company’s hematopoietic stem/progenitor and other primary cell products used for drug discovery, regenerative medicine, cell-based assay development, and other research applications. Jay Tong M.D., the Company’s President & CEO, commented, “The facilities expansion is an important step towards executing our strategic growth plan, enabling AllCells to increase production capacity and continue providing the best possible service to our customers.” Dr. Tong added, “We have experienced dramatic growth over the past few years; in a recent market survey, >90% of AllCells’ customers reported being very satisfied with our products & service, with more than one third expecting to increase their business.”

The Company has simultaneously expanded staff in several areas. Wayne Vaz recently joined the Company as VP, Corporate & Business Development, previously serving with Millipore Corp. and Serologicals Corp. in the areas of Technology & Alliance and Corporate Business Development & Strategic Planning. Headcount has also been expanded within the areas of Sales & Marketing, Laboratory Operations, and Accounting. Dr. Tong further commented, “We are pleased to have talented individuals joining us from some of the industry’s top life science companies. We are focused on strengthening our core competencies to build AllCells’ business going forward.”

About AllCells LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.